The hepatic veins are the liver’s drainage system, carrying all of the organ’s processed blood back to the heart by emptying into the inferior vena cava just below the diaphragm. Most people have three major hepatic veins, designated right, middle, and left, though the exact branching pattern varies considerably from person to person. These vessels sit at the intersection of nearly every major liver condition, from cirrhosis to transplant surgery, making them one of the most clinically consequential vein groups in the body.
How the Three Main Hepatic Veins Are Arranged
The standard textbook picture shows three large trunks converging on the inferior vena cava like branches meeting a tree trunk. The right hepatic vein drains the right side of the liver. The middle and left hepatic veins often merge into a shared channel before reaching the inferior vena cava. In a study using three-dimensional CT scans of 200 people, about 61% had this shared trunk pattern, while the remaining 39% had all three veins draining independently.
A larger imaging study of 500 patients found broadly similar numbers but with some differences in proportion: roughly 81% showed a common trunk for the middle and left hepatic veins, while 19% had independent drainage of both into the inferior vena cava.1PubMed Central. Hepatic vein variations in 500 patients: surgical and radiological significance The right hepatic vein was a single vessel in about 92% of those patients. These numbers highlight that while most people follow the textbook blueprint, a meaningful minority do not.
Smaller veins matter too. In many people a right inferior hepatic vein provides backup drainage for the right lobe, and a vein serving segment four of the liver may empty into either the left or the middle trunk, or occasionally straight into the inferior vena cava.2PubMed. Anatomical variations of hepatic veins: three-dimensional computed tomography scans of 200 subjects A cadaveric study from South India found that the most common classification types for each vein occurred in only 30 to 70% of specimens, underscoring how much variation exists even within a single population.3PubMed Central. Anatomical variations of the hepatic veins: an observational study from a single cadaveric lab in South India
Why Variation Matters for Surgeons
This variation is far from academic. During liver resections, surgeons must preserve enough venous outflow to keep the remaining liver tissue alive. If you have a large accessory right hepatic vein, a surgeon might safely remove more of the right lobe than usual because that accessory vessel picks up the slack. If you do not, the same operation risks leaving part of the liver congested and oxygen-starved. Preoperative CT or MRI mapping of the hepatic veins has become routine for exactly this reason.4PubMed Central. Anatomy of Hepatic Resectional Surgery
The stakes are even higher in liver transplantation. In a technique called piggyback transplant, the donor liver is sewn onto the recipient’s remaining hepatic vein openings rather than replacing the entire segment of the inferior vena cava. A case report described a patient who developed a high-grade narrowing with torsion at this connection two months after transplant, leading to fluid buildup and atrophy of part of the new liver.5PubMed Central. Hepatic venous outflow obstruction after piggyback liver transplantation by an unusual mechanism: report of a case Research into recipient vein drainage patterns has found that certain configurations make this outflow obstruction more likely, with twisting and compression being the main culprits depending on which group the patient falls into.6Annals of Transplantation. Risk Factors for Hepatic Venous Outflow Obstruction in Piggyback Liver Transplantation: The Role of Recipient’s Pattern of Hepatic Veins Drainage into the Inferior Vena Cava
How Blood Flows Through the Hepatic Veins
The liver is unusual in that it receives blood from two sources: the hepatic artery, which supplies oxygen-rich blood, and the portal vein, which brings nutrient-laden blood from the gut. Both streams mix as they percolate through the liver’s microscopic sinusoids, tiny channels lined by specialized endothelial cells. The filtered blood collects first in central veins within each liver lobule, then drains into progressively larger hepatic veins, and finally reaches the inferior vena cava.
Those central veins are more than passive pipes. They produce signaling molecules that help establish the metabolic zones within each lobule, determining which liver cells specialize in tasks like drug metabolism and which focus on other functions.7PubMed Central. The Hepatic Central Vein: Structure, Fibrosis, and Role in Liver Biology When liver disease causes fibrosis around these central veins, that signaling environment breaks down, potentially disrupting the liver’s ability to organize its work efficiently.
On ultrasound, hepatic vein blood flow has a distinctive pulsing pattern driven by the heartbeat. A normal waveform shows four phases tied to the heart’s contractions and relaxations, with two of those phases representing blood moving toward the heart.8PubMed. Understanding the spectral Doppler waveform of the hepatic veins in health and disease This triphasic (three-peaked) pattern is what doctors look for. When the liver stiffens from cirrhosis, that pulsing flattens out. A study of cirrhosis patients found that about 73% had a flat, monophasic waveform, and most of those patients had the most advanced disease.9PubMed Central. Hepatic Venous Waveform, Splenoportal and Damping Index in Liver Cirrhosis: Correlation with Child Pugh’s Score and Oesophageal Varices In other words, the shape of the hepatic vein’s blood-flow tracing doubles as a rough gauge of how stiff and scarred the liver has become.
Measuring Portal Pressure Through the Hepatic Veins
One of the most valuable clinical uses of the hepatic veins is as an access point for measuring portal pressure, the pressure in the vein that feeds the liver from the gut. The test involves threading a catheter through the neck’s jugular vein, down into a hepatic vein, and inflating a small balloon to temporarily block flow. The difference between the blocked (wedged) pressure and the free-flowing pressure is called the hepatic venous pressure gradient, or HVPG.
HVPG is considered the best available measure of portal hypertension, which is the dangerous pressure buildup that drives many of the worst complications of cirrhosis: swollen esophageal veins that can rupture and bleed, fluid accumulation in the abdomen, and confusion from toxins the liver can no longer clear.10PubMed Central. Hepatic venous-portal gradient (HVPG) measurement: pearls and pitfalls When the gradient exceeds about 10 mmHg, those complications start becoming a real risk.11PubMed Central. Hepatic venous pressure gradient: clinical use in chronic liver disease Beyond diagnosis, repeated HVPG measurements help doctors track whether medications are working to lower portal pressure, decide whether someone with liver cancer can safely undergo surgery, and gauge how fast fibrosis is worsening over time.12PubMed Central. Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement
The development of hepatic vein catheterization itself has an interesting backstory. It grew out of early right-heart catheterization techniques about 80 years ago, initially used to measure blood flow through the liver’s territory. Pressure measurements came a few years later, eventually leading to the HVPG concept and to procedures like transjugular liver biopsy, where a needle is passed through the hepatic vein into liver tissue, avoiding the risks of puncturing through the abdominal wall in patients whose blood does not clot well.13PubMed Central. On the History of Hepatic Vein Catheterization
When Hepatic Veins Get Blocked
Blockage of the hepatic veins is the hallmark of Budd-Chiari syndrome, a rare but serious condition that affects roughly one in 100,000 people. The blockage causes blood to back up in the liver, leading to congestion, swelling, and oxygen starvation of liver cells. At least two of the three major hepatic veins typically need to be blocked before obvious symptoms appear, because the liver has enough drainage redundancy to compensate for losing one.14PubMed Central. Budd-Chiari syndrome: etiology, pathogenesis and diagnosis
The presentation ranges widely, from people who have no symptoms at all to those who develop sudden liver failure. About three-quarters of patients have an underlying blood-clotting disorder, and in a quarter, more than one contributing factor is at play. Blood cancers that affect the bone marrow are the single most common underlying cause.15PubMed Central. Budd-Chiari syndrome: etiology, pathogenesis and diagnosis There is an important distinction between clots forming in the hepatic veins themselves and disease affecting the stretch of the inferior vena cava where the hepatic veins enter. The two patterns tend to look different clinically. Clots in the hepatic veins proper are more often linked to clotting disorders and can cause severe or even sudden liver failure, while disease in the cava itself tends to have a milder, more gradual presentation.16PubMed. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion
A related condition seen mainly in parts of Asia and Africa involves a web or membrane forming where the hepatic veins meet the inferior vena cava. This was long assumed to be a birth defect, but more recent thinking ties it to localized infection-driven inflammation that triggers clotting, which then scars into a membrane over time. The condition can remain silent for years, punctuated by flare-ups, but it carries a significant risk of cirrhosis and liver cancer over the long term.17PubMed Central. Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava) In children with this type of obstruction, balloon dilation through a catheter has been used successfully to reopen the blocked segment.18The Turkish Journal of Pediatrics. Budd-Chiari syndrome in a child secondary to membranous obstruction of the hepatic vein treated by percutaneous transluminal angioplasty report of a case
Sinusoidal Obstruction Syndrome
While Budd-Chiari involves blockage of the large hepatic veins, sinusoidal obstruction syndrome (sometimes still called veno-occlusive disease) attacks the microscopic end of the drainage system. The tiny endothelial cells lining the liver’s sinusoids swell, peel away from the underlying tissue, and clump together downstream, plugging the smallest veins. The result is congestion and damage that can mimic the effects of a large-vein blockage but originates at a much finer scale.19PubMed Central. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)
The sequence of events is remarkably specific. Damaged endothelial cells swell, allowing red blood cells to squeeze through widening gaps into the space between the sinusoidal lining and the liver cells. This peeling effect sends fragments of the lining downstream, where they form emboli that obstruct the tiniest venules. In animal studies, infusing glutathione, one of the body’s main protective molecules, prevented the entire cascade from even starting.20PubMed. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome This suggests that the trigger is a depletion of the cell’s own antioxidant defenses.
The condition is best known as a complication of bone-marrow transplant, where high-dose chemotherapy damages the sinusoidal lining. But it also occurs after exposure to certain plant-derived toxins. A case report documented sinusoidal obstruction in a patient who had consumed a tea made from a plant in the ragwort family, which contains pyrrolizidine alkaloids known to be toxic to sinusoidal endothelial cells.21PubMed. Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case report Outbreaks tied to contaminated grain or herbal remedies have been documented in several countries.
The Liver as a Mirror of Heart Failure
Because the hepatic veins empty into the inferior vena cava just below the heart, any rise in the heart’s right-sided pressures reverberates back into the liver almost immediately. In right-sided heart failure, blood backs up through the inferior vena cava and into the hepatic veins, engorging the liver. This passive congestion can push liver enzymes and bilirubin levels up, sometimes enough to mimic liver disease in someone whose liver is structurally normal.22PubMed Central. Liver abnormalities in cardiac diseases and heart failure
Doctors sometimes discover this backward when a patient shows abnormal liver tests and the workup eventually leads not to the liver but to the heart. The connection can also run in the other direction: in children born with single-ventricle heart defects who undergo the Fontan operation (which reroutes blood flow to bypass the missing ventricle), chronically elevated venous pressure transmits directly to the liver through the hepatic veins. Computational modeling of these patients predicts increasing portal pressures and reduced blood flow through the liver tissue as this Fontan-associated liver disease progresses, with wall shear stress rising in the hepatic veins themselves.23PubMed Central. A One‐Dimensional 1D Computational Fluid Dynamics Study of Fontan‐Associated Liver Disease FALD These children face a slow-motion form of liver injury driven entirely by abnormal venous hemodynamics rather than by any intrinsic liver disease.
TIPS and Other Interventional Procedures
The hepatic veins serve as the starting point for one of the most important interventional procedures in liver medicine: the transjugular intrahepatic portosystemic shunt, or TIPS. The idea is to create an artificial channel through the liver tissue connecting a hepatic vein to a branch of the portal vein, relieving the pressure buildup in the portal system. A metal stent holds the channel open. The procedure is used when medications and endoscopic treatments fail to control complications of portal hypertension like variceal bleeding or stubborn ascites.
Which hepatic vein gets used for TIPS can affect outcomes. A study comparing right versus middle hepatic vein access found that both routes achieved similar pressure reductions after the shunt was placed, dropping the portal-systemic gradient from about 17 mmHg to around 7.5 to 8 mmHg.24PubMed Central. Right versus Middle Hepatic Vein access and One-Year TIPS Outcomes The middle hepatic vein route used smaller-diameter shunts more often yet still performed comparably, giving interventional radiologists flexibility when the right hepatic vein is hard to access or has unfavorable anatomy.
Sometimes the standard approach fails entirely, particularly when liver scarring is so severe that the usual landmarks are distorted. A newer technique combines ultrasound and fluoroscopic guidance to puncture both the hepatic and portal veins simultaneously through a single needle pass across the liver. This cross-sight approach has enabled successful shunt placement in cases where the conventional method could not find a viable path.25PubMed Central. Cross-sight transjugular intrahepatic portosystemic shunt (CS-TIPS): combined ultrasound-fluoroscopy guidance for simultaneous percutaneous portal and hepatic vein puncture and access closure with plug deployment
Researchers are also working toward non-invasive alternatives to the pressure measurements that currently require catheterizing the hepatic veins. A study using four-dimensional flow MRI combined with computational fluid dynamics was able to estimate the portal-systemic pressure gradient without any catheter. The non-invasive estimates correlated strongly with invasive measurements and correctly identified whether the gradient was above or below a clinically meaningful threshold in 80% of patients tested.26PubMed Central. Four-dimensional Flow MRI-based Computational Fluid Dynamics Simulation for Noninvasive Portosystemic Pressure Gradient Assessment in Patients with Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt If validated in larger groups, this kind of tool could reduce the need for repeated invasive catheterizations in people with chronic liver disease.
How Hepatic Veins Form Before Birth
The hepatic veins do not develop the way most veins in the body do. During embryonic life, the liver grows around two sets of early veins: the vitelline veins, which drain the yolk sac, and the umbilical veins, which carry oxygenated blood from the placenta. As liver cells (hepatoblasts) multiply, they engulf these vessels. Over time, parts of the vitelline veins remodel into the portal vein and the hepatic veins, while the umbilical veins mostly regress after birth when the placental circulation shuts down.27PubMed Central. The fate of the vitelline and umbilical veins during the development of the human liver
This developmental history explains why the hepatic veins are embedded within the liver tissue rather than running along its surface like many other veins. It also helps explain the wide range of anatomical variation seen in adults: small differences in how the embryonic veins remodel can produce different numbers of branches, different trunk patterns, and different drainage territories.
Trauma and the Vulnerability of Hepatic Veins
The hepatic veins’ position deep within the liver makes them both protected and dangerous. In blunt abdominal trauma, the liver is one of the most commonly injured organs, and damage to the hepatic veins is among the most lethal patterns of liver injury. A review from a major trauma center found that hepatic vein injuries were a significant driver of the high death rate from blunt liver trauma.28JAMA Surgery. Management of Blunt Trauma to the Liver and Hepatic Veins The problem is partly anatomical: these veins sit near the back of the liver, close to the inferior vena cava, in a spot that is difficult to access surgically. Bleeding from a torn hepatic vein also tends to be profuse and hard to control because the low-pressure venous system does not clamp down the way arterial vessels do.
Even in non-traumatic settings, the hepatic veins are vulnerable when medical devices pass through them. In newborns who receive umbilical venous catheters, a thread-like tube inserted through the stump of the umbilical cord to deliver fluids and medications, the catheter tip sometimes migrates into or through a hepatic vein. A five-year review at one center found that about 21% of neonates who experienced catheter-related liver complications developed hepatic vascular clots during follow-up.29PubMed. Hepatic extravasation complicated by umbilical venous catheterization in neonates: A 5-year, single-center experience Confirming catheter tip position with imaging has become standard practice to minimize this risk.